Variant Philadelphia t(X;9;22)(q22?;q34;q11.2) can be successfully treated with second generation tyrosine kinase inhibitors: A case report and literature review

por Iglesias, Ana, Oancea, Raluca, Cotarelo, Carmen, Anguita, Eduardo
Publicado 2021

Transcription Factor GFI1B in Health and Disease

por Anguita, Eduardo, Candel, Francisco J., Chaparro, Alberto, Roldán-Etcheverry, Juan J.
Publicado 2017

HTLV-1 infection: An emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases

por Eusebio-Ponce, Emiliana, Anguita, Eduardo, Paulino-Ramirez, Robert, Javier Candel, Francisco
Publicado 2019

PB1817: THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION

por Sofía, Álvarez-Galeano, Salazar-Hidalgo, Milton, Benavente, Celina, López-Lorenzo, José Luis, Anguita, Eduardo
Publicado 2023

Seroprevalence and Trends of HTLV-1/2 among Blood Donors of Santo Domingo, Dominican Republic, 2012-2017

por Eusebio-Ponce, Emiliana, Candel, Francisco Javier, Paulino-Ramirez, Robert, Serrano-García, Irene, Anguita, Eduardo
Publicado 2020

Autoimmune neutropenia associated with influenza virus infection in childhood: a case report

por Callejas Caballero, Ignacio, Illán Ramos, Marta, Berzosa Sánchez, Arantxa, Anguita, Eduardo, Ramos Amador, José Tomás
Publicado 2021

Abnormal Dendritic Cell-poiesis in Patients With Lower-risk Myelodysplastic Syndromes

por Sánchez, Ángela, Anguita, Eduardo, Chaparro, Alberto, Roldán-Etcheverry, Juan José, López-García, Alberto, Ramos-Acosta, Carlos, Oancea, Raluca, Rodriguez-Muñoz, Diego, Alemany, Susana
Publicado 2020

Alterations in the immune system persist after one year of convalescence in severe COVID-19 patients

por Abarca-Zabalía, Judith, González-Jiménez, Adela, Calle-Rubio, Myriam, López-Pastor, Andrea R., Fariña, Tomás, Ramos-Acosta, Carlos, Anguita, Eduardo, Urcelay, Elena, Espino-Paisán, Laura
Publicado 2023

TIM3, a human acute myeloid leukemia stem cell marker, does not enrich for leukemia-initiating stem cells in B-cell acute lymphoblastic leukemia

por Bueno, Clara, Martínez, Alba, Romecin, Paola Alejandra, Zanetti, Samanta Romina, Tirtakusuma, Ricky, Genesca, Eulalia, Camós, Mireia, Ramírez-Orellana, Manuel, Anguita, Eduardo, Ballerini, Paola, Locatelli, Franco, Fuster, José Luis, Menéndez, Pablo
Publicado 2023

C3G, through its GEF activity, induces megakaryocytic differentiation and proplatelet formation

por Ortiz-Rivero, Sara, Baquero, Cristina, Hernández-Cano, Luis, Roldán-Etcheverry, Juan José, Gutiérrez-Herrero, Sara, Fernández-Infante, Cristina, Martín-Granado, Víctor, Anguita, Eduardo, de Pereda, José María, Porras, Almudena, Guerrero, Carmen
Publicado 2018

Bone Marrow Clonogenic Myeloid Progenitors from NPM1-Mutated AML Patients Do Not Harbor the NPM1 Mutation: Implication for the Cell-Of-Origin of NPM1+ AML

por Diaz de la Guardia, Rafael, González-Silva, Laura, López-Millán, Belén, Rodríguez-Sevilla, Juan José, Baroni, Matteo L., Bueno, Clara, Anguita, Eduardo, Vives, Susana, Palomo, Laura, Lapillonne, Helene, Varela, Ignacio, Menendez, Pablo
Publicado 2020

Free triiodothyronine levels and age influences the metabolic profile and COVID-19 severity parameters in euthyroid and levothyroxine-treated patients

por Amich, Inés, Anguita, Eduardo, Escribano-Serrat, Silvia, Alvarez, Cristina, Rodríguez-Muñoz, Diego, García, Verónica, Bello, Rocío, Peña-Pedrosa, José Alberto, Martínez-Micaelo, Neus, Amigó, Nuria, Ortiz, Pablo, Torrejón, María José, Boscá, Lisardo, Martín-Sánchez, Javier, Aranda, Ana, Alemany, Susana
Publicado 2022

Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes

por Diaz de la Guardia, Rafael, Lopez-Millan, Belen, Lavoie, Jessie R., Bueno, Clara, Castaño, Julio, Gómez-Casares, Maite, Vives, Susana, Palomo, Laura, Juan, Manel, Delgado, Julio, Blanco, Maria L., Nomdedeu, Josep, Chaparro, Alberto, Fuster, Jose Luis, Anguita, Eduardo, Rosu-Myles, Michael, Menéndez, Pablo
Publicado 2017

Correction: Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune r...

por Raneros, Aroa Baragaño, Minguela, Alfredo, Rodriguez, Ramon M., Colado, Enrique, Bernal, Teresa, Anguita, Eduardo, Mogorron, Adela Vasco, Gil, Alberto Chaparro, Vidal-Castiñeira, Jose Ramon, Márquez-Kisinousky, Leonardo, Bulnes, Paula Díaz, Marin, Amelia Martinez, García Garay, Maria Carmen, Suarez-Alvarez, Beatriz, Lopez-Larrea, Carlos
Publicado 2018

Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition

por Raneros, Aroa Baragaño, Puras, Alfredo Minguela, Rodriguez, Ramon M., Colado, Enrique, Bernal, Teresa, Anguita, Eduardo, Mogorron, Adela Vasco, Gil, Alberto Chaparro, Vidal-Castiñeira, Jose Ramon, Márquez-Kisinousky, Leonardo, Bulnes, Paula Díaz, Marin, Amelia Martinez, Garay, García Maria Carmen, Suarez-Alvarez, Beatriz, Lopez-Larrea, Carlos
Publicado 2017

Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib

por Marcé, Sílvia, Xicoy, Blanca, García, Olga, Cabezón, Marta, Estrada, Natalia, Vélez, Patricia, Boqué, Concepción, Sagüés, Miguel, Angona, Anna, Teruel-Montoya, Raúl, Ferrer-Marín, Francisca, Amat, Paula, Hernández-Boluda, Juan Carlos, Ibarra, Mariana M., Anguita, Eduardo, Cortés, Montserrat, Fernández-Ruiz, Andrés, Fontanals, Sandra, Zamora, Lurdes
Publicado 2021

A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia

por Primo, Daniel, Scarfò, Lydia, Xochelli, Aliki, Mattsson, Mattias, Ranghetti, Pamela, Espinosa, Ana Belén, Robles, Alicia, Gorrochategui, Julian, Martínez-López, Joaquín, de la Serna, Javier, González, Marcos, Gil, Alberto Chaparro, Anguita, Eduardo, Iraheta, Sandra, Munugalavadla, Veerendra, Quéva, Christophe, Tannheimer, Stacey, Rosenquist, Richard, Stamatopoulos, Kostas, Ballesteros, Joan, Ghia, Paolo
Publicado 2018

The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia

por Lopez-Millan, Belen, Costales, Paula, Gutiérrez-Agüera, Francisco, Díaz de la Guardia, Rafael, Roca-Ho, Heleia, Vinyoles, Meritxell, Rubio-Gayarre, Alba, Safi, Rémi, Castaño, Julio, Romecín, Paola Alejandra, Ramírez-Orellana, Manuel, Anguita, Eduardo, Jeremias, Irmela, Zamora, Lurdes, Rodríguez-Manzaneque, Juan Carlos, Bueno, Clara, Morís, Francisco, Menendez, Pablo
Publicado 2022

PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase

por Alonso-Dominguez, Juan M., Casado, Luis Felipe, Anguita, Eduardo, Gomez-Casares, Maria Teresa, Buño, Ismael, Ferrer-Marín, Francisca, Arenas, Alicia, Del Orbe, Rafael, Ayala, Rosa, Llamas, Pilar, Salgado, Rocio N., Osorio, Santiago, Sanchez-Godoy, Pedro, Burgaleta, Carmen, Mahíllo-Fernández, Ignacio, Garcia-Gutierrez, Valentin, Steegmann, Juan Luis, Martinez-Lopez, Joaquín
Publicado 2017

A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia

por Onecha, Esther, Linares, Maria, Rapado, Inmaculada, Ruiz-Heredia, Yanira, Martinez-Sanchez, Pilar, Cedena, Teresa, Pratcorona, Marta, Oteyza, Jaime Perez, Herrera, Pilar, Barragan, Eva, Montesinos, Pau, Vela, Jose Antonio Garcia, Magro, Elena, Anguita, Eduardo, Figuera, Angela, Riaza, Rosalia, Martinez-Barranco, Pilar, Sanchez-Vega, Beatriz, Nomdedeu, Josep, Gallardo, Miguel, Martinez-Lopez, Joaquin, Ayala, Rosa
Publicado 2019